| Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants L Ley, F Holze, D Arikci, AM Becker, I Straumann, A Klaiber, F Coviello, ... Neuropsychopharmacology 48 (11), 1659-1667, 2023 | 22 | 2023 |
| The pharmacological profile of second generation pyrovalerone cathinones and related cathinone derivative KE Kolaczynska, J Thomann, MC Hoener, ME Liechti International journal of molecular sciences 22 (15), 8277, 2021 | 20 | 2021 |
| Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma J Thomann, L Ley, A Klaiber, ME Liechti, U Duthaler Journal of pharmaceutical and biomedical analysis 220, 114980, 2022 | 11 | 2022 |
| Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6 … J Thomann, SB Vogt, A Guessoum, M Meyer, M Vogel, ME Liechti, ... Journal of Chromatography B 1237, 124104, 2024 | 1 | 2024 |
| In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin J Thomann, KE Kolaczynska, OV Stoeckmann, D Rudin, P Vizeli, ... Frontiers in Pharmacology 15, 1391689, 2024 | | 2024 |
| Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers D Luethi, D Rudin, I Straumann, J Thomann, I Avedisian, ME Liechti, ... Journal of Chromatography B, 124123, 2024 | | 2024 |
Matthias LiechtiUniversity Hospital BaselVerified email at usb.ch
